HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
epidermal alloantigen 1
histocompatibility antigen; expressed on epidermal cells
Also Known As:
Epa-1; epidermal alloantigen-1
Networked:
3
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Biological Factors: 2472
Antigens: 143924
Isoantigens: 1221
epidermal alloantigen 1: 3
Related Diseases
1.
Neoplasms (Cancer)
11/01/1980 - "
This method allows EPA-1 to be detected in human serum in an amount of 4 to 100 ng/ml. The high levels of EPA-1 (over 4 ng/ml) were observed in all cases (27 patients) of tumors of connective tissues, in 50 of 51 in brain tumors, in 39 of 341 in gastrointestinal tract tumors, in 4 of 13 in breast tumors, and in 21 of 51 tumors of the respiratory tract.
"
05/01/1986 - "
Oncofetal antigens TSAP, EPA-1, EPA-2 and CEA characteristic for antigenic reversion of thyroid tumors were identified in thyroid tissues.
"
2.
Thyroid Neoplasms (Thyroid Cancer)
05/01/1986 - "
CEA and EPA-1 identification in the patients' blood sera could be applied to serological diagnosis of thyroid cancer.
"
3.
Graft vs Host Disease (Graft-Versus-Host Disease)
08/01/1986 - "
Epa-1 is a tissue-restricted, non-major histocompatibility (MHC) antigen that may be responsible for the extreme sensitivity of skin to allograft rejection and graft-versus-host disease (GVHD), especially with MHC-compatible donors and recipients.
"
4.
Breast Neoplasms (Breast Cancer)
11/01/1980 - "
This method allows EPA-1 to be detected in human serum in an amount of 4 to 100 ng/ml. The high levels of EPA-1 (over 4 ng/ml) were observed in all cases (27 patients) of tumors of connective tissues, in 50 of 51 in brain tumors, in 39 of 341 in gastrointestinal tract tumors, in 4 of 13 in breast tumors, and in 21 of 51 tumors of the respiratory tract.
"
5.
Brain Neoplasms (Brain Tumor)
11/01/1980 - "
This method allows EPA-1 to be detected in human serum in an amount of 4 to 100 ng/ml. The high levels of EPA-1 (over 4 ng/ml) were observed in all cases (27 patients) of tumors of connective tissues, in 50 of 51 in brain tumors, in 39 of 341 in gastrointestinal tract tumors, in 4 of 13 in breast tumors, and in 21 of 51 tumors of the respiratory tract.
"
Related Drugs and Biologics
1.
Antigens
2.
oncofetal antigens
3.
tartrate-sensitive acid phosphatase